# Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

> **NCT01223612** · PHASE4 · COMPLETED · sponsor: **Moorfields Eye Hospital NHS Foundation Trust** · enrollment: 37 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Ranibizumab
- **PROCEDURE:** Modified ETDRS laser

## Key facts

- **NCT ID:** NCT01223612
- **Lead sponsor:** Moorfields Eye Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01223612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01223612, "Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01223612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*